en-GBlv-LVru-RU
en-GBlv-LVru-RU
NEWS

 

May 17, 2022

An international group of experts will work on the improvement of a comprehensive cancer infrastructure / network in Latvia

On May 17 and 18, the experts from the International Agency for Research on Cancer (OECI) and the International Agency for Research on Cancer IARC) are visiting Latvia as part of project “Improvement of Cancer Care Coordination and Screening in Latvia and Slovakia”. One of the main goals is meeting of the Comprehensive Cancer Infrastructure / Network Working Group.

The aim of the visit of the experts and the meeting of the working group is to get acquainted with the current situation in Latvia and to find out the preconditions for the development of an improved cancer care infrastructure in line with OECI European standards. As a result, the experts are to propose a strategic plan adapted to the situation in Latvia, marking also the time plan for the implementation of the proposals.

This is a project funded by the European Commission's (EC) Technical Assistance Instrument (DG REFORM). The project will lead to a reduction in cancer mortality, improved cancer registration, accreditation of comprehensive cancer care and research infrastructures / networks, and improved breast, cervical and colorectal cancer screening programs.

The working group is to discuss the progress and current issues of the project implementation, as well as get acquainted with the activities of the Latvian institutions:

Hospitals:

  • Riga East University Hospital
  • Children’s University Hospital
  • P. Stradins Clinical University Hospital

Universities and Research Institutes:

  • Riga Stradins University
  • University of Latvia
  • Latvia Biomedical Research and Study Centre
  • Institute of Organic Synthesis

Government Ministries

  • Ministry of Education and Science
  • Ministry of Environment Protection and Regional Development
  • Latvia Academy of Science

On the second day of the visit, experts are to get acquainted with the work of Children’s University Hospital, as well as visit the Biobank, the State Genome Database of the State and the LU KPMI clinical and research laboratories.

The visit will be concluded by a conversation with the Minister of Health Daniels Pavļuts and a meeting with the Rector of RSU, Prof. Aigars Petersons, as well as university researchers.

May 9, 2022

Within the framework of the VOGAS project, the team of LU KPMI is visiting partners in Brazil

From May 7 to 16 our team representing the VOGAS project - Director of the Institute of Clinical and Preventive Medicine of the University of Latvia, head of the VOGAS clinical group of the project Prof. Mārcis Leja, research assistant of the project Linda Mežmale and leading researcher of the institute Inese Poļaka - meets with cooperation partners in South America, Brazil.

In Manaus and the São Paulo Clinical Center, the team is conducting a detailed analysis planning, discussing clinical activities at each center, providing an up-to-date insight into project outcomes, and continuing the development of the breath test screening / early detection equipment, started in the VOGAS project.

The project „Screening of Gastric Cancer via Breath volatile organic compunds by Hybrid Sensing Approach” has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No  824986

April 28, 2022

A scientific article on Digestive cancer screening across Europe has been published

Among the authors of the paper "Digestive cancer screening across Europe" - LU professor, gastroenterologist, LU KPMI director Mārcis Leja, along with Patrizia Burra, Michael Bretthauer, Maria Buti Ferret, Ana Dugic, Pierluigi Fracasso, Tamara Matysiak Budnik, Patrick Michl, Luigi Ricciardiello, Thomas Seufferlein, Monique van Leerdam, and Andreea Botos.

This position paper presents available evidence and the main issues that need to be addressed to ensure the successful implementation of screening for the four cancers - gastric, colorectal, liver and pancreatic cancer -, providing recommendations to aid informed decision-making in reducing the burden of digestive cancers across Europe.

The paper is available online at the "United European Gastroenterology Journal": http://doi.org/10.1002/ueg2.12230

© Photo: Book publishing photo created by Racool_studio - www.freepik.com

April 25, 2022

LU KPMI’s specialists have participated in a seminar on Development of Biobanks for the Needs and Discoveries of the Next Generation of Science

On 22nd April, the seminar “Development of Biobanks for the Needs and Discoveries of the Next Generation of Science” took place at the Academic Center of the University of Latvia.

Biobanking in the world is moving into a direction of personalized medicine enhancement and clinical and omics data driven AI projects potentially enabling next-generation medical discoveries. The aim of this seminar was to show-case these tendencies and forward the situation in Latvian biobanking network to develop resources and competences for the contemporary research needs. This seminar ensured knowledge transfer within Latvian Biobanking network to increase biobanking resource sustainability in Latvia and collaboration with major international players.

The event hosted presentations from:

The Head of the scientific council of the Latvian Biomedical Research and Study Center Prof. Jānis Kloviņš,

Chairman of the Board of the Children's Clinical University Hospital Valts Ābols,

The Head of Genome Database of Latvian population Dr.biol. Vita Rovīte,

As well as Director Prof. Mārcis Leja, and Assoc. Prof., Leading researcher, Bioethics Specialist Signe Mežinska of LU KPMI.

© Photo: Lecture hall photo created by jannoon028 - www.freepik.com

April 14, 2022

We wish you a Happy Easter!

Please note we will be out of office enjoying the celebration from Friday, 15th April until Tuesday, 19th April.

April 11, 2022

The scientific research center work in Liepāja has been presented to the media

In presence of media representatives, a press conference - informative presentation on the launch of the Liepāja Research Center was held. Its aim was to tell of the practical processes and importance of the research emphasizing the benefits of a timely diagnosis of a disease.

For successful results of the study, gentlemen aged 40 to 64 are especially invited to apply for participation in the study. The center in Liepāja is open at Jūrmalas Street 23 every working day from 7:00 to 13:00. To apply and receive a free gastrointestinal examination (screening) please call 25679868

© Photo: from personal archive: the team of the Liepāja research center

The project is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project ‘Practical Studies’, 4th phase, project ID Nr. 1.1.1.1/20/A/035 ‘Hybrid-sensor breath analysis for colorectal cancer screening’

April 10, 2022

Finnish partners have been hosted in Latvia

At the end of March, LU KPMI hosted the partner of the projects VOGAS and A-Patch, the senior research scientist of the VTT Technical Research Centre of Finland, Veikko Ikonen. During his stay, he visited the clinical partner of the LU KPMI - Riga East University Hospital  Latvian Oncology Centre and Tuberculosis and Lung Disease Center (TLDC) as well as met with the medical staff of the LU KPMI. Employees who work with patients on a daily basis presented the clinical activities of the A-Patch and VOGAS projects, patient recruitment processes, the conduct of breath tests, and VOC detection from the surface of skin. V. Ikonen was also introduced with the LU KPMI Biobank and the processes of collection and storage of biological samples of patients. The main ethical aspects of the study, ensuring a safe conduct of the study for patients, were also discussed during the meeting.

© Photo: from personal archive: from left: Veikko Ikonen, the senior research scientist of the VTT Technical Research Centre of Finland; Aija Kārkliņa, LU KPMI’s medical nurse; Viktors Veliks, the senior research scientist of LU KMPI

© Photo: from personal archive: A-Patch clinical process by Ruta Deklava, TLDC / LU KPMI nurse

The project „Screening of Gastric Cancer via Breath volatile organic compunds by Hybrid Sensing Approach” has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No  824986

The project „Autonomous Patch for Real-Time Detection of Infectious Disease” has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824270

April 6, 2022

Press conference - informative presentation on the launch of the Liepaja Research Center

On Monday, April 11 at 14:00 in Liepāja, 23 Jūrmalas Street media representatives are invited to a press conference - informative presentation on the launch of the Liepāja Research Center - a joint research project of the Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI) and Liepāja Regional Hospital.

Attendees will be able to find out the most significant benefits of the opening of the research center in Liepāja, what is the GISTAR study and HYCOR project, what are their goals and tasks, as well as to get acquainted with the research process in Liepāja.

Please apply for participation by sending an e-mail to amanda.boka@lu.lv

Participating:

Aiga Rūdule, LU KPMI senior expert, administrative manager of GISTAR research

Andris Vistiņš, HYCOR project partner - Liepāja Regional Hospital Board Member

Dr. Mārcis Leja, LU professor, gastroenterologist, LU KPMI director, scientific manager of GISTAR research and HYCOR project

Context:

Each year, 3.88 million new cases of digestive system cancers are detected worldwide. About 2.83 million people die of them annually. Latvia belongs to a high-risk area with 600 people diagnosed with gastric cancer every year. About 500 patients die due to gastric cancer every year. Colorectal cancer (cancer of the large intestine) and cancer of the stomach are among the most common digestive cancers. Most of the cancers are preventable; if diagnosed early, most of the cancers, including colorectal and gastric cancers are treatable successfully.

GISTAR is a scientific study aiming to reduce mortality from gastric cancer. It aims to search for new intervention strategies to prove the efficacy of gastric cancer screening and optimize colorectal cancer screening in high-risk areas.

Free gastrointestinal examinations (screenings) of the population aged 40-64 are performed in regional research centers, with an aim of developing screening methods for the earliest possible diagnosis of the disease. The obtained data help improving the efficiency of systematic research of gastrointestinal tumors.

HYCOR is a scientific project based on the GISTAR study, which aims to promote the concept of an exhaled volatile marker in colorectal cancer screening by promoting the development of a new hybrid analyzer for this purpose.

More about LU KPMI, scientific project HYCOR and research GISTAR: www.kpmi.lu.lv; www.gistar.eu

The project is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project ‘Practical Studies’, 4th phase, project ID Nr. 1.1.1.1/20/A/035 ‘Hybrid-sensor breath analysis for colorectal canec screening.

March 31, 2022

Closing the project dedicated to prevention of gastric cancer, its results have been presented at an international conference

With a participation in the International Scientific Conference on Medicine 2022, the LU KPMI ERDF project No. 1.1.1.1/18/A/184 “Optimization of H. pylori eradication scheme for mass gastric cancer prevention measures” has been closed. At the conference, the results of the project were presented by research assistants Olga Sjomina and Reinis Vangravs:

During the project, the team has succeeded in achieving the intended and have obtained the necessary data that have been analysed to prepare a total of five scientific articles. Three of them have been already published and two have been submitted and awaiting for publication:

  1. "Early detection of gastric cancer beyond endoscopy - new methods"  Best Practice & Research Clinical Gastroenterology,Volumes 50–51, March–April 2021, 101731, https://doi.org/10.1016/j.bpg.2021.101731
  2. Sjomina et al., "Randomised clinical trial: comparison of efficacy and adverse effects of a standard triple clarithromycin-containing regimen with high-dose amoxicillin and bismuth therapy in Helicobacter pylori eradication", 'European Journal of Cancer Prevention', https://journals.lww.com/eurjcancerprev/toc/publishahead
  3. Sabine Skrebinska et.al., “Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?”, https://www.mdpi.com/2075-4418/12/1/133/htm
  4. Razuka-Ebela Danute et.al., “Factors associated with false negative results in serum pepsinogen testing for precancerous gastric lesions in a European population in the GISTAR study”, submitted to journal „Diagnostincs” on 31.03.2022.
  5. Vangravs Reinis et.al., “Clarithromycin-containing triple therapy for H. pylori eradication is inducing increased long-term gut resistome”, submitted to journal “Alimentary Pharmacology and Therapeutics” on 31.03.2022.

© Photo: Vintage microphone photo created by jannoon028 - www.freepik.com

The Project is implemented by ERDF (European Regional Development Fund ) within the framework of 2nd part of measure 1.1.1.1. "Practical Studies", project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

March 28, 2022

The International Scientific Conference on Medicine is over

From March 25 to 26, 2022, the International Scientific Conference on Medicine took place within the framework of the 80th Scientific Conference of the University of Latvia. The conference covered various disciplines of clinical and research medicine, pharmacy, public health. For epidemiological security reasons, all sessions took place online on the Zoom platform.

Researchers of the Institute of Clinical and Preventive Medicine of the University of Latvia and students involved in the research work participated in the conference with several reports and e-stand reports:

The theses prepared by the participants are summarized and published in Appendix 1 of the 58th issue of the internationally cited journal “Medicina”.

March 25, 2022

Researchers and students of LMI KPMI participate in the international scientific conference of medicine

This year, the International Scientific Conference of the University of Latvia celebrates its 80th anniversary and its meetings in medicine and pharmacy will take place on 25-26. in March. This year's event takes place remotely on the Zoom platform. Researchers of the Institute of Clinical and Preventive Medicine and students involved in research work have been participating in the conference for several years already, and this year is no exception.

Those interested can follow the conference work virtually. The program of the event and Zoom access links, as well as e-stand reports are published on the conference website. The theses prepared by the participants are compiled in a revised thesis stock and issued in Annex 1 to number 58 of the internationally quoted journal “Medicina”.

© Photo: Toms Grīnbergs, LU Communication Department.

March 18, 2022

Visits of foreign experts and participation in the Congress "On Equality in Overcoming Cancer" continue

On the third day of the visit, the leaders of the project “Improving the Coordination and Screening of Cancer Care in Latvia and Slovakia” funded by the European Commission's Technical Assistance Facility (DG REFORM) visited the private practice of general practitioner Dr. Andris Baumanis and visited the Central Laboratory.

© Photo from personal archive
 
Photos of foreign experts visit the private practice of general practitioner Andris Baumanis

After the visits of international experts, the guests participated in the congress "On Equality in Overcoming Cancer", where one of the speakers was the director of the University of Latvia KPMI Mārcis Leja with a lecture "Tools on how to implement EU Cancer Mission's recommendations at national levels".

 

© Photo from personal archive
 
In the picture Mārcis Leja

March 17, 2022

Foreign experts continue visits within the framework of the project “Improvement of Cancer Care Coordination and Screening in Latvia and Slovakia”

Specialists from the International Agency for Research on Cancer and the ERASMUS Medical Center have visited the Children's Clinical University Hospital, the polyclinic of the Association of Health Centers PULSS-5, the Laboratory of Academic Histology.

The first monitoring group meeting and press conference took place after the on-site visits, during which the participants were informed about the project “Improving cancer care coordination and screening in Latvia and Slovakia” funded by the European Commission's Technical Assistance Instrument (DG REFORM) funded project “Improvement of Cancer Care Coordination and Screening in Latvia and Slovakia” (ICCCS), initiated by the Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI).

"More than 12 thousand people are diagnosed with cancer in Latvia every year, but about 6 thousand die from cancer. Colorectal cancer is the most common type of cancer in Latvia, but breast cancer is in third place. The burden of cancer from both cancers can be reduced through a population-based, high-quality cancer screening program, ”said Dr. Andre Carvalho adds that effective cancer screening programs save lives by detecting tumors at an early stage and increasing their chances of survival. These measures prevent unnecessary suffering and death. In turn, data collection through high-quality cancer data recording is essential for effective cancer control policies and epidemiological research. These data form the basis for planning public health programs to prevent cancer and improve patient care, explains Dr. Andre Carvale.

Read more here.

© Photographer: Evija Trifanova
In the photo, foreign experts and members of the monitoring committee (from left: Dr. Partha Basu, Daniels Pavļuts, Aris Zakatistovs, Dr. Andre Carvalho)

March 16, 2022

Project “Improvement of Cancer Care Coordination and Screening in Latvia and Slovakia” is Launched

The Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI) informs Europe's first comprehensive cancer care improvement project "Improving Cancer Care Coordination and Screening in Latvia and Slovakia" in Latvia is launched. In the project foreign experts will provide recommendations for the development of a strategic plan and a roadmap that will reduce cancer-related mortality in cooperation with national partners.

Within the framework of the project, foreign experts from the International Agency for Research on Cancer (IARC) and the ERASMUS Medical Center (Rotterdam, the Netherlands), as well as the Organization of European Cancer Institutes (OECI) have visited Latvia for several days. During the visit experts will provide their expertise to improve processes and implement the necessary services.

On March 16, foreign experts visited the current services in the field of cancer in Latvia. The guests visited the Riga East Clinical University Hospital, the Diagestive Diseases Center "Gastro", the Latvian Center for Disease and Prevention and the National Health Service (see photo).

  

© Photo from personal archive
 
The photographs include visits by foreign experts to the Riga East Clinical University Hospital, the Digestive Diseases Center "Gastro" and the National Health Service.

March 16, 2022

Data from the LU KPMI project have been presented at the International Gastric Cancer Congress IGCC 2022

The International Gastric Cancer Congress (IGCC 2022) of the International Gastric Cancer Association (IGCA) took place from 6 to 9 March in Houston, Texas (USA), in a hybrid format (remotely in an epidemiologically safe environment).

Manohar Prasad Bhandari, a leading researcher at the Institute of Clinical and Preventive Medicine of the University of Latvia, gave a remote stand presentation at the postdoctoral research project ‘Study of the relation between gastric microbiota and VOCs for the early detection of gastric cancer’ no. 1.1.1.2/VIAA/3/19/495. In his study, Bhandari analyzed volatile organic compounds derived from gastric cancer tissue and healthy gastric tissue identifying compounds that differ from cancerous and healthy tissue. It is planned to further analyze these compounds and use them in human exhalation analysis to determine the risk of gastric cancer, as well as in the development of non-invasive gastric cancer detection devices.

Manohar Prasad Bhandari’s postdoctoral project goal is to investigate the effects of volatile compounds, microbial changes, and exhaled markers on gastric microbiome for an early diagnosis of gastric cancer.

Program "Growth and Jobs" 1.1.1. Specific support objective “Increase the research and innovation capacity of Latvian scientific institutions and the ability to attract external funding by investing in human resources and infrastructure” 1.1.1.2. ERDF project No. of the measure “Support for postdoctoral research” 1.1.1.2/VIAA/3/19/495 "Study of the relation between gastric microbiota and VOCs for the early detection of gastric cancer"

March 15, 2022

Mārcis Leja: The voice of cancer patients must be heard

On the portal Delfi.lv you can read a conversation with the director of the Institute of Clinical and Preventive Medicine of the University of Latvia, a member of the steering committee of the Congress of European Oncology Patient Organizations “On Equality in Overcoming Cancer” prof. Mārci Leju, on the importance of cancer patients' views in improving the quality of cancer care, current issues in cancer care, the European Congress of Oncology Patients' Congress on Equality in Cancer and the European Oncology Patients' common position in the congress's open letter.

You can read the article here.

Cancer Equality

Find out more about the European Congress of Oncology Patients' Congress on Equality in Cancer here

You will also be able to follow the congress online all day long on the Facebook account of the Onaliance with a translation into Latvian.

March 14, 2022

In the congress in Riga, European oncology patients will request to end the humiliating cancer treatment inequality

On 18 and 19 March a unique event in the field of oncology in the Baltics will take place in Riga, Latvia – the European Congress of Oncology Patient Organizations “On Equality in Beating Cancer”. It aims to prevent inequalities in cancer diagnosis, treatment, access to innovative medicines, and other areas.

The event is organized by the Latvian Association of Oncology Patient Organizations "Oncoaliance" in cooperation with the Special Committee on Beating Cancer (BECA) of the European Parliament. The event is co-organized by influential patient organizations of Central and Eastern Europe (CEE) countries – Romania, Greece, Estonia, Lithuania, the Czech Republic, Poland, etc.

Congress participants together with more than 30 internationally recognized experts – patient advocacy leaders, teachers, doctors, politicians, representatives of national governments and the European Parliament (EP) – will identify the causes of inequality in cancer care and request the CEE region health policy officials and decision-makers to address them so that cancer patients who are living in this part of the European Union (EU) would receive the same modern, innovative cancer care as in the EU's welfare states. Mārcis Leja Professor at the University of Latvia, Director of the Institute of Clinical and Preventive Medicine of the University of Latvia, former member of the Board of the EU Cancer Mission will speak in Congress as one of the speakers.

Read more about the event - HERE

Cancer Equality

March 9, 2022

Free testing for gastro-intestinal diseases

As part of ERDF project No 1.1.1.1/20/A/035 “Hybrid-sensor breath analysis for colorectal cancer screening - HYCOR”, the University of Latvia's Institute of Clinical and Preventive Medicine, in cooperation with Liepaja Regional Hospital, has started to carry out free gastro-intestinal disease tests for 40-64-year-olds.

Gastro-intestinal disease tests are performed in the Liepaja study centre: Jurmala Street 23, Liepaja. Study Centre working time 7:00 - 13:00. To sign in for free exams, please call 25 679 868.

More about the project – HERE

The project is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 4th phase, project ID Nr. 1.1.1.1/20/A/035."

March 3, 2022

Training is being provided for the staff of the Liepaja Research Center

From 1.-11. training for future employees of the GISTAR Research Center is taking place at the Liepaja Research Center. Training is organized both on-site and remotely, according to epidemiological requirements. On March 2 a lecture for participants was given by ERDF project no. 1.1.1.1/20/A/035 “Hybrid-sensor breath analysis for colorectal cancer screening - HYCOR” Leading Researcher Marcis Leja. In the Microsoft Teams environment, Mārcis Leja introduced the research staff to the GISTAR research, the current issues of gastric and intestinal cancer in Latvia and in the world. The youngest scientists of the project Arnis Kiršners, Daiga Šantare and Sergejs Paršutins also took part in the training as teachers. During the training, the new team is introduced to the research website, data usage and security rules, GISTAR data management system, research protocol and inclusion of research participants, as well as collaboration with GPs and specialists at the local level.

© Photo from personal archive - photo with employees of Liepaja Research Center (from left side: Zanda Atmata, Agneta Freimane, Laura Rišmite)

The project is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 4th phase, project ID Nr. 1.1.1.1/20/A/035."

March 3, 2022

The online Meeting Of Minds 4 from 23. till 24. february gathered over 100 patients, researchers, clinicians and caregivers around the question ,,How can new technologies better support patients?“

The event aimed at engaging patients and gathering important feedback from end-users. They were given the opportunity to share their insight and contribute to design better tools based on their needs as cancer patients and survivors. The Cluster members presented their projects with an overview of their work, the scope of their research and how they apply new technology in their solution designs.

Ten EU funded projects were presented during the event: MENHIR, LIFECHAMPS, ONCORELIEF, FAITH, PERSIST, QUALITOP, CLARIFY, ASCAPE, REBECCA, CAPABLE.

Project PERSIST was presented by its coordinator Victoria Cal. Gazihan Alankus from Gradiant and one of the app developers Gazihan Alankus from EMODA. They made a demonstration of the patients’ mHealth app of PERSIST.

One of the most exciting parts of the event was the roundtable discussion with cancer patients, who were invited to provide their insights on series of questions, related to trust in new technologies, patients’ participation in studies, data sharing and patients’ motivation to participate in the design of research of innovative digital health solutions.

Learn more: Meeting of Minds 4.

Persist on Twitter  Persist website

© Photos from PERSIST Blog - http://bit.ly/3C0nKvH

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

February 17, 2022

Chance to apply for free conference - Transforming Healthcare with AI

Deloitte Baltics, in partnership with digital marketing agency Adore, is inviting data practitioners, pharmaceutical companies, and public and private health organizations to join a free artificial intelligence(AI) and machine learning technology healthcare conference to discuss the various operational challenges faced by AI in the Baltics.

Transforming Healthcare with AI conference will take place online on 22 of February 2022, 9:30 – 15:00 EET.

Inese Polaka, leading researcher at the Institute of Clinical and Preventive Medicine, will also participate in the conference with a presentation “Experience and potential in clinical research: application of ML in process improvement and gaining new insights”. Un which she will speak about institute previous experience with AI and machine learning in medical data analysis, process improvement and introduction of new technologies, as well as planned applications of artificial intelligence and machine learning.

Find out more about the conference.

Registration application form for the conference.

February 9, 2022

PERSIST is organizing a mini-symposia session on "Digital Health Interventions and Big Data for Personalized Cancer Survivorship" within ICCMSE 2022. The event will take place on October 26-29, 2022 in Crete, Greece. The session is dedicated to discussing the use of real-world data, big data, information technologies, and artificial intelligence to support cancer survivors and patients. Although primarily focused on solutions for cancer survivors and patients, any contribution towards improving (HR)QoL, using real-world data is welcome.

Deadline for submission: Extended Abstracts (3-4 pages) should be submitted by 06 August 2022. (Requirements can be seen here).

Information about the fees, registration and logistics can be found at the ICCMSE 2022 official website: www.iccmse.org.

  Persist website

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

February 8, 2022

Researchers should think about professional ethics

Photo: LU Photo archive

Photo: LU Photo archive

In October 2021, the first ethics committee for sectoral groups was set up at the University of Latvia (LU). After that On 2022 of January Maris Zander had a conversation with the chairman of the LU Committee on Ethics for Life and Medicine Studies, associate professors of the University of Latvia and lead researcher of the Institute of Clinical and Preventive Medicine, Signe Mezinska about, why researchers should think about professional ethics. Article is published in Latvian. Read more about the conversation they had in the winter number of the edition “Alma Mater”, 2022.

February 4, 2022

#PERSIST joins people and organizations worldwide in commemorating World Cancer Day on February 4. This day is dedicated to the courage and achievements of people living with cancer and calls for everyone to join in helping to save lives.

Learn more here.

See a Twitter post  Persist website

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

January 26, 2022

How can new technologies better support patients?

Find the answer on February 23-24 where the #CS_AIW Cluster will hold its 4th Meeting of Minds - the first to be open to the public, as patients and survivors will be part of the audience.

Learn more: https://bit.ly/3FXqsCn

Learn more  Persist website

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

January 25, 2022

Dr. Apinis and the audience get acquainted with the HYCOR project

Yesterday, January 24, ERDF project no. 1.1.1.1/20/A/035 Professor Marcis Leja, Head and Leading Researcher of “Hybrid-sensor breath analysis for colorectal cancer screening - HYCOR” was on channel TV24 broadcast “Dr.Apinis - What's New in Gastroenterology”.
During the show, Marcis Leja told about the latest scientific research in the field of gastroenterology, as well as introduced the listeners to the HYCOR study.
The recording of the show can be watched here: part one and  part two. *The recording of the show is available in Latvian.

Screenshot from the “Dr.Apinis - What's New in Gastroenterology” on the 24.01.2022. 

© Screenshot from the “Dr.Apinis - What's New in Gastroenterology” on the 24.01.2022. (From left: LU Professor, Director of the Institute of Clinical and Preventive Medicine of the UL and Leading Researcher Mārcis Leja, Assistant Professor of the Department of Internal Medicine, RSU Vita Skuja, Head of the Clinic of RAKUS Gastroenterology, Hepatology and Nutrition Aleksejs Derovs Peter Apinis.)

The project is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 4th phase, project ID Nr. 1.1.1.1/20/A/035."

January 21, 2022

Project participants have submitted theses to the International Conference on Scientific Medicine

The International Scientific Medicine Conference of the University of Latvia will take place on March 25-26, 2022. Five participants of the project “Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention” on the following topics have submitted theses to the conference, section of medicine and health science:

- “The Use of Shotgun Metagenomic Sequencing for Detection of H. Pylori Pre- and Post-Eradication: Bioinformatics Feasibility Assessment”, autori Vangravs Reinis, Čivkulis Kristaps, Ļeonova Elīna, Dauss Edgars, Poļaka Inese, Sjomina Olga, Leja Mārcis;

- “Evaluation of Dietary Habits of Jekabpils Inhabitants: Adherence to Nordic Diet and Association With Helicobacter Pylori Infection”, autori Jurkevica Ineta, Daugule Ilva, Kojalo Ilona, Poļaka Inese, Paršutins Sergejs, Leja Mārcis, Šantare Daiga;

- “Addition of Saccharomyces Boulardii to Standard Triple Therapy in Eradication of H. pylori: Comparison of Adverse Events and Effectiveness”, autori Sjomina Olga, Suhorukova Jekaterina, Rūdule Aiga, Vangravs Reinis, Paršutins Sergejs, Poļaka Inese, Daugule Ilva, Stonāns Ilmārs, Park Jin Young, Leja Mārcis.

We invite you to follow the conference and find out what was found in the study!

80th International Scientific Conference of the UL 

The study is financed by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

January 17, 2022

The first HYCOR project particiapnts are included

Institute of Clinical and Preventive Medicine of the University of Latvia in cooperation with the Latvian Oncology Center has started the clinical activities of the HYCOR project, ensuring the recruitment of colorectal cancer patients for the project.

Patients with a confirmed diagnosis of colorectal cancer are invited to participate in the study. Patients are provided with information about the study, its goals, and the opportunity to donate breath samples and tissue material obtained during the operation for the study. Currently, the project includes 21 study participants with colorectal cancer.

The project is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 4th phase, project ID Nr. 1.1.1.1/20/A/035."

January 14, 2022

Abstract submission deadline for the 80th International Scientific Conference of the UL extended

The International Scientific Conference on Medicine is traditionally held at the Faculty of Medicine as part of the annual international scientific conference staged by the University of Latvia (UL), bringing in industry experts both from Latvia and from abroad. The UL Conference celebrates its 80th anniversary this year. The event begins every time with an academic plenary session. Afterwards, the conference work is organised in section meetings, including the field of medicine and health sciences.

The International Scientific Conference on Medicine activities will be held online on March 25-26, 2022. In efforts to foster the spirit of international collaboration, participation is free of charge. Certificates of attendance with credit points for further education will be awarded to participants of the event.

The abstracts should be submitted via the UL Conference platform, the deadline has been extended to Sunday, January 23. Every UL employee has their own profile on the website. Please find below the illustrative images of how to access the platform. For additional enquiries, please contact the organiser or send your question to the Department of Science.

December 27, 2021

On the extension of the VOGAS project activities

The World Health Organization declared the spread of COVID-19 to be a Public Health Emergency of International Concern on January 30, 2020 and a pandemic on March 11, 2020. In order to protect their population from possible infection with COVID-19, most countries, including our project partners' ones, announced the state of emergency which caused limited job opportunities at the institutions.

It should be stressed that the COVID-19 pandemic situation significantly affected the VOGAS project activities. The tight restrictions limited the work of all partners and thereby the progress of the research. These pandemic-related problems include delays in the purchase/delivery of laboratory consumables and materials due to the broken supply chains, delays and complications during the transport of samples between laboratories, and limited human resources etc.

For these reasons, the project has now been extended till September 2022.

 

VOGAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 824986

December 21, 2021

Merry Christmas and Happy New Year 2022!

December 15, 2021

Publication on the PERSIST project idea in its current perspective is available

A blog post from the Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI) has been made available on the PERSIST project website. LU KPMI participates in the above-mentioned international project since 2020.

The publication highlights such issues as the quality of life of cancer patients and survivors, the basic idea of the PERSIST project, and the main benefits of digital interventions in healthcare.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

December 14, 2021

Invitation to a seminar of the Doctoral school in translational medicine at the University of Latvia

The Doctoral school in translational medicine at the University of Latvia invites to participate in a seminar on the topic "The Nordic diet and the characteristics of intestinal microbiota" which will take place at 3:30 p.m., December 15. The event will be conducted by M.D. Daiga Šantare, a leading researcher at the Institute of Clinical and Preventive Medicine of the University of Latvia.

During the seminar, Ilze Birka, a gastroenterologist and doctoral student at the University of Latvia, will tell about the intestinal microbiota and factors influencing it. Participants will have an opportunity to learn how the Nordic diet can affect the intestinal microbiota of both healthy people and patients in cases of certain diseases. Also, participants of the seminar will be told which foods from the Baltic Sea diet pyramid have the greatest influence.

To register as Doctoral school or only seminar participant, please follow this link.

Illustration of the Baltic Sea Diet Pyramid

December 10, 2021

LU KPMI project data have been presented at GASTRO 2021 Prague

On December 9-11, 2021, at the O2 Universum, Prague's most modern multifunctional cultural and congress center, is being held GASTRO 2021 Prague, arranged by the World Gastroenterology Organisation (WGO) in partnership with the Czech Society of Gastroenterology (ČGS) in hybrid format, featuring in-person sessions with a virtual component.

Today, Olga Sjomina, a doctoral student at the Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI), presented data obtained from the GISTAR study “Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention” funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase (project ID No. 1.1.1.1/18/A/184).

The project aims to reduce gastric cancer mortality by eradicating Helicobacter pylori and determining pepsinogen levels. This would allow to detect an increased risk of gastrointestinal stromal tumors in a timely manner.

In the picture - Olga Sjomina

The GISTAR study is co-financed by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

December 3, 2021

The involvement of participants for the GISTAR study at the Kuldīga Regional Centre has been finished

On December 2, the inclusion of participants for the GISTAR study was successfully completed. From May 10 to December 2, 2021, a total of 679 respondents were involved at this centre. The research administrative manager, Ms Aiga Rūdule, thanked the Kuldīga Regional Centre staff for their great work.

In Latvia, the GISTAR study was launched in Cēsis town already in October 2013; and it has also taken place in such Latvian cities and towns as Alūksne, Ludza, Saldus, Tukums, Dobele, Jēkabpils, Madona, and Rēzekne so far.

It must be added that 10 381 respondents were included in the study since its beginning in 2013 until early December this year. Work with participants is currently continuing on the evaluation of the effectiveness of H.pylori eradication therapy.

 

© Aiga Rūdule. In the picture, from left to right: Elita Zazerska, Lienīte Pūpola, and Mārīte Lagzdiņa (Elīna Kronlaka and Sandra Reimane were absent when the photo was taken).

November 15, 2021

Apskatīt attēlu

The fifth anniversary event of LU KPMI has come

November 15 marks five years since the founding of the Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI). In honour of the event, the virtual meeting will be on Zoom starting at 3:30 p.m., November 16. The key members of administrative staff of the University of Latvia will be present to look back on what has been reached and to thank all those who have significantly contributed to the development of LU KPMI.

Many employees of LU KPMI were involved in the process of organising the informal part of the event by suggesting their colleagues for various unofficial nominations, for example, 'The Perpetuum Mobile of LU KPMI', 'The Know-It-All of LU KPMI', 'The Most Frugal Employee of LU KPMI', 'The Enthusiast of the LU KPMI Boldest Ideas', 'The Voice of Reason of LU KPMI', and for several others intriguing nominations.

The employees of LU KPMI were invited to show their gratitude to the closest colleagues for a special performance or support as well as to write both serious and humorous wishes for the Institute itself and its further development. The employees of LU KPMI expressed many colourful wishes, among them were achieving their desired outcomes, at the same time enjoying the beautiful road towards these goals; doubling the number of employees and tripling the number of projects; in poetic form expressed self-irony about the importance of one's own personality.

The live broadcast of the official event will also be available on the Facebook account of LU KPMI.

November 1st, 2021

International experts will study how to improve cancer care in Latvia

The European Commission has approved the project “Improving cancer care coordination and screening in Latvia and Slovakia” (DG REFORM), initiated by LU KPMI. The project was launched on November 1, involving ministries and oncology specialists, and will become one of the measures for the development of the industry. The main goal of the project is to propose a strategic plan tailored to the needs of Latvia and Slovakia, which will contribute to reducing cancer mortality, improve cancer registration, achieve comprehensive accreditation of cancer care and research infrastructures / networks, and improve breast, cervical and colorectal cancer screening programs.

At present, Latvia and Slovakia lag behind EU Member States in terms of performance in terms of continuity of cancer care and, in particular, screening programs. In Latvia, cancer registries have not provided up-to-date statistics for the last two years. Data logging platforms are not able to provide data acquisition and exchange in accordance with current requirements. Cancer screening programs, on the other hand, have a number of shortcomings, the most important of which is the lack of clearly defined responsibilities. Several ministries contribute to cancer policy, but the level of coordination is not always satisfactory. There is also no accredited cancer care center in the country that could facilitate strategic planning for cancer control. Therefore, the new DG REFORM project will help to improve the situation.

October 25th, 2021

Inform about cancer research and afterpatient care

On October 28, at 14:00, a press conference of Riga East Clinical University Hospital and the University of Latvia will take place online to inform about current events in the aftercare of cancer patients both in the context of the European Union (EU) Cancer Mission Council recommendations and research, as well as on the progress of the international innovation project PERSIST.
The press conference is organized by the Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI) and Riga East Hospital (RAKUS), which actively cooperate in the field of education and research, implementing several important joint projects, especially in the field of cancer research. The conference will be attended by: Professor Mārcis Leja (Director of LU KPMI), Professor Haralds Plaudis (Member of the Board of Riga East Hospital), Ilmārs Stonāns (Deputy Director of LU KPMI), Krista Arcimoviča (Surgeon of Riga East Hospital) and Gunita Berķe (Chairman of the Board of the Association of Oncological patients "Dzīvības koks").
The live broadcast of the press conference will also be available on the Facebook account of the University of Latvia.

Read more about the event HERE.

   

October 20th, 2021

Scientific paper has been prepared for publication on the comparison of efficacy and adverse effects in Helicobacter pylori eradication

Having analysed data, obtained from the project ID No. 1.1.1.1/18/A/184 “Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention” co-financed by the European Regional Development Fund, Olga Sjomina, a scientific assistant at the Institute of Clinical and Preventive Medicine of the University of Latvia, together with a research project team, has prepared a scientific paper titled “Randomised clinical trial: comparison of efficacy and adverse effects of a standard triple clarithromycin-containing regimen with high-dose amoxicillin and bismuth therapy in Helicobacter pylori eradication.”

The article has been accepted for publication in one of the next issues of the European Journal of Cancer Prevention. https://journals.lww.com/eurjcancerprev/Abstract/9000/Randomised_clinical_trial__comparison_of_efficacy.98999.aspx

The GISTAR study is co-financed by the European Regional Development Fund 1.1.1.1. measure "Practical Studies", 2nd phase, project ID No. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention".

 

October 17th, 2021

The preparatory work of the HYCOR project is being successfully implemented!

From July to October, preparation work for the project “Hybrid-sensor breath analysis for colorectal cancer screening (HYCOR)" was started. After the preparation work, it will be possible to start the clinical activities of the project.

During this time period physicians and researchers worked to develop a general clinical project protocol which will be used throughout the study. Also standard operating procedure protocols were created, as well as questionnaires and data collection software were updated, which will be used to enter information about each participant in the project. The criteria for the selection of subjects were also defined and a scheme for recruiting participants was developed.

The project is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 4th phase, project ID Nr. 1.1.1.1/20/A/035.

October 16th, 2021

Marcis Leja in Belgium took part in a scientific conference “40 years of Science for the Future. Prevention of cancer is effective and affordable”

On October 16, 2021 in Belgium (Elzart), near Brussels, a scientific conference on the topic was organized to celebate the 40th anniversary of the European Cancer Prevention organization (ECP) and the 30th anniversary of its journal - European Journal of Cancer Prevention.

ECP was established in 1981 to unite the forces of European researchers in the field of cancer prevention as well as to assure the leading positions of the European researchers in this topic globally.

The Director of the Institute of Clinical and Preventive medicine Mārcis Leja reported on the progress of the GISTAR study, which is currently underway in ERDF project no. 1.1.1.1/18/A/184 “Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention”, as well as informed about the ongoing research on exhaled volatile markers in Latvia. He also spoke about a project to reduce stomach cancer mortality submitted to the GAIA-X Health Platform, supported by the European Commission. Professor Carlo La Vecchia of Italy (Milan) reported on international collaboration in the STOP consortium to analyze risk factors for gastric cancer; Latvian researchers also participate in this consortium. In the following informal talks, one of the founders of ECP, prof. Alain Maskens (Belgium) praised the achievements of Latvia, as well as the achievements of the StoP project, highlighting these results as ECP's efforts over many years.

 

Photo (from the left): Prof. Carlo La Vecchia and the President of  ECP Prof. Jaak Janssens

 

The study is financed by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

October 14th, 2021

A seminar of the participants of the international research project PERSIST was held

Today, October 14, a seminar of the PERSIST project was held. PERSIST is a cancer survivor care plan based on Big Data and Artificial Intelligence technologies.
In the first part of the seminar, Dr. med. Daiga Shantare with delivered a lecture “Healthy diet for patients after cancer treatment”. In the second part, the technical partners of the study, together with the participants, assessed the work of the new health application mHealth. Feedback and suggestions from participants will help technical partners to improve the PERSIST system.
After completing cancer treatment, the PERSIST study participants received smartwatches and smartphones with the new mHealth application, which helps doctors monitor their health. Thus, it will be possible to provide patients with personalized care. The project is international, and its clinical part with the involvement of patients is taking place not only in Latvia, but also in Belgium, Slovenia and Spain. In Latvia, the PERSIST clinical trial is implemented by the Institute of Clinical and Preventive Medicine of the University of Latvia.

  

*This project has received funding from the European Union’s “Apvārsnis 2020” research and innovation programme under grant agreement No 875406

October 11th, 2021

Professor Marcis Leja will be the guest editor of the special edition of DIAGNOSTICS magazine

International open access journal DIAGNOSTICS announces a special issue "Advances in the Detection and Screening of Gastric Cancer" that will be guest-edited by Mārcis Leja, the Director of the Institute of Clinical and Preventive Medicine, University of Latvia
Submissions are invited in the following topic areas: ongoing studies globally in gastric cancer screening and early detection; new and emerging methods for early detection and screening for gastric cancer and gastric precancerous lesions; surveillance strategies for patients with gastric precancerous lesions; H.pylori related disease; the role of microbiota; artificial intelligence; data collaboratives and large data in gastric cancer prevention.
Please see more detailed information on the special issue, as well as manuscript submission information HERE.

 

October 5th, 2021

The participants of the VIRT2UE project share a positive experience

The project VIRT2UE implemented by the Institute of Clinical and Preventive Medicine of the University of Latvia is nearing completion. During the project, 20 participants from Latvia, Lithuania, Estonia and Poland have already obtained certificates in the trainings organized by the University of Latvia.

Project participants - LU doctoral students Zanda Rubene and Reinis Upenieks trained 26 doctoral students in educational sciences at the University and share positive experience HERE.

*This project has received funding from the European Union’s “Apvārsnis 2020” research and innovation programme under grant agreement No 787580.

October 4th, 2021

Marcis Leja presented Cancer Mission Recommendations and the plan to implement the recommendations

A presentation of the European Cancer Mission Board Recommendations and the plan to implement the recommendations was delivered by the member of the Cancer Mission Board Mārcis Leja during the United Gastroenterology Week (UEGW). The oncology-related areas which are expected to be supported by the European Commission were highlighted.

September 29th, 2021

Director of LU KPMI participated in the President's visit to Slovenia

On Wednesday, September 29, LU KPMI director Marcis Leja, together with Latvian President Egils Levits, Slovenian President Borut Pahor and medical colleagues, took part in the signing of an academic cooperation agreement between the Slovenian National Institute of Public Health, the Slovenian Association of Gastroenterology and Hepatology and the University of Latvia.

During the visit, common EU activities in oncology were discussed, as well as Slovenia's experience in developing and implementing a nationwide cancer screening program. Meeting with scientists, the President acknowledged the need for purposeful and holistic planning of cancer screening programs in Latvia.

Over the last ten years, Latvian researchers have collaborated extensively with Slovenian specialists, including on issues related to cancer screening and, in particular, the prevention of digestive system tumors. Several projects have been planned and submitted jointly with the aim of obtaining EU funding, including the Horizon Europe project submitted a few days ago under the leadership of the University of Latvia on cooperation in the field of big data for the prevention of gastric cancer. Taking into account the epidemiological situation typical of Slovenia and Latvia, Slovenian specialists called on the Latvian side to support the development of new scientific projects for cooperation between the two countries for the primary and secondary prevention of gastric cancer.

    

Photos by: Ilmārs Znotiņš, Valsts prezidenta kanceleja.

September 28th, 2021

LU KPMI project "Volatile Marker Breath Analyzer for Gastric Cancer Screening" has been completed

Today, 28 September, the project of the Institute of Clinical and Preventive Medicine of the University of Latvia "Volatile Marker Breath Analyzer for Gastric Cancer Screening" has been completed. The project is based on the clinical need to introduce a screening method for the early detection of gastric cancer and precancerous changes. The goal of the project is to identify gastric cancer and precancerous conditions using nanosensors that detect volatile organic compounds, as well as to develop a modern portable nanosensor express analyzer for screening gastric cancer and precancerous conditions. The project was implemented over a period of 36 months, starting from September 28, 2018.

The clinical part of the project was implemented under the leadership of KPMI Director Marcis Leja in close cooperation with specialists from the Latvian Oncology Center of Riga Eastern Clinical University Hospital and the GASTRO Digestive Diseases Centre. Within the framework of the project, many clinical activities were carried out involving patients and testing of equipment in a clinical conditions.

Before starting work in the clinic, a validation study of portable express analyzers was initially successfully implemented, which helped to evaluate the repeatability and variability between all devices, thus it was possible to start the next stage of the project - "Clinical validation study" with real patients. The study included patients with a confirmed diagnosis of gastric cancer and patients with high-risk changes, as well as control patients with a known condition of the gastric mucosa. The main goal of this project section was to develop a model that would differentiate the studied changes from the control measurements, so that in the future this model could be used for individuals with well-defined gastric changes. A total of 198 patients participated in this study, including 81 gastric cancer patients and 117 subjects from the control group. In parallel, a "Validation study in the general population" was carried out. The research took place in Jekabpils regional GISTAR center. In total, breath samples from 392 participants of the regional GISTAR center were obtained on all three analyzers.

Based on the data obtained in the clinic, a mathematical model was developed and the specificity and sensitivity of 16 different volatile organic compound sensors were evaluated, identifying exhaled air from cancer patients as opposed to exhaled air from healthy people. The specificity of this mathematical model, the parameter induction of which is performed from the measurement data when tested on a new data set, significantly exceeds the performance of any individual sensor parameter. Work on commercialization is currently ongoing.

  

September 27th, 2021

Highlights of the project "Information and Communication Technology Competence Center" in the third quarter of 2021

IT competence center in accordance with the agreement No.1.2.1.1/18/A/003 concluded with the Central Finance and Contracts Agency on May 9, 2019. implements the project “Information and Communication Technology Competence Center”.

In June, SIA “Datorzinību centrs” study No. 1.5 “Ensuring interoperability of the creation, migration and use of e-learning objects in the cloud computing infrastructure”. The study developed a model and algorithms that significantly improve the existing content creation tools, ensure wider availability of content on Moodle and Open edX e-learning platforms in accordance with HTML5 and specialized e-learning standards (SCORM). Research was also carried out to develop concepts and algorithms for a cloud-based learning content migration tool and to ensure the portability of content from the Moodle e-learning platform to Open edX. As a result of the research, prototypes of both tools have been created, and the validation of these developments has also been performed.

 

The project is co-financed by the European Regional Development Fund Operational Program "Growth and Jobs" 1.2.1. Specific objective 1.2.1.1 of the Specific objective "Increase private sector investment in R&D". the measure "Support for the development of new products and technologies within centers of competence"

September 22th, 2021

LU KPMI participated in the development of a record number of seven projects in the framework of Horizon Europe

Yesterday, September 21, the call for applications for the next competition of projects Horizon Europe in the thematic group "Health" was completed.

This time LU KPMI participated in the development of a record number of seven projects in cooperation with 95 partners from 25 countries.

Projects were submitted in four research areas:

  1. Staying healthy in a rapidly changing society;
  2. Living and working in a health-promoting environment;
  3. Tackling diseases and reducing disease burden;
  4. Ensuring access to innovative, sustainable and high-quality health care.

Many thanks to all colleagues for the work done!

September 12th, 2021

Scientific-practical conference "Multidisciplinary approach in gastroenterology" was held in St. Petersburg

On September 10 and 11, St. Petersburg hosted the next, fifth, scientific and practical conference with international participation "Multidisciplinary approach in gastroenterology". Since the conference was organized in a virtual format, a wide range of participants could take part in it, including those outside the second largest Russian metropolis. Questions related to autoimmune gastritis were selected for discussion within the framework of the round table. M.Leja was also invited to participate as an international expert.
During the discussion, M.Leja presented an initiative of international collaboration on data exchange to optimize the diagnosis and treatment of gastric cancer and precancerous lesions (‘Data collaborative in gastric cancer and precancerous lesions’). M.Leja expressed the opinion that such a model of cooperation could make a significant contribution to the detection and control of autoimmune gastritis.

Copyright 2016 - 2022 by LU KPMI